VDI
AVNS

Vaughan David Investments’s Avanos Medical AVNS Stock Holding History

Vaughan David Investments’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,457
Closed -$268K – 153
2015
Q1 		$268K Sell
5,457
-12,416
-69% -$575K 0.02% 140
2014
Q4 		$813K Buy
+17,873
New +$702K 0.05% 103

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vaughan David Investments's AVNS Position: Q2 2015 in Review

Vaughan David Investments sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 5,457 shares — an estimated $268K sold.

Vaughan David Investments first reported a position in AVNS in Q4 2014 and held it in 2 quarters. The position peaked at $813K in Q4 2014. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • Vaughan David Investments reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
  • Vaughan David Investments sold 5,457 Avanos Medical shares in Q2 2015, an estimated $268K.
  • Vaughan David Investments first reported a position in Avanos Medical in Q4 2014 and held it in 2 quarters.
  • Vaughan David Investments's Avanos Medical position peaked at $813K in Q4 2014.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Vaughan David Investments's 13F filing for Q2 2015, filed 6 Aug 2015.